Cargando…

Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use

The comparative outcomes of specific aminoglycosides in cavitary type (fibrocavitary or cavitary nodular bronchiectatic type) Mycobacterium avium complex (MAC) pulmonary disease (PD) are unelucidated. We investigated the treatment outcomes with streptomycin or amikacin inclusion in the treatment reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seong Min, Chong, Yong Pil, Lee, Hyun Joo, Shim, Tae Sun, Jo, Kyung-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269653/ https://www.ncbi.nlm.nih.gov/pubmed/37022189 http://dx.doi.org/10.1128/spectrum.04741-22

Ejemplares similares

Outcome of shorter treatment duration in non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease
por: Park, Yea Eun, et al.
Publicado: (2020)

Radiologic Subtypes and Treatment Outcome of Unclassifiable Type Mycobacterium avium Complex Pulmonary Disease
por: Lee, Jang Ho, et al.
Publicado: (2022)

Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio According to the Radiologic Severity of Mycobacterium avium Complex Pulmonary Disease
por: Kim, Mi-Ae, et al.
Publicado: (2022)

Amikacin liposome and Mycobacterium avium complex: A systematic review
por: Zangiabadian, Moein, et al.
Publicado: (2022)

Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series
por: Davis, Kala K, et al.
Publicado: (2007)

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020)

Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Mycobacterium avium Complex Lung Disease
por: Kwon, Yong Shik, et al.
Publicado: (2020)

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates
por: Kim, Su-Young, et al.
Publicado: (2021)

From Penicillin-Streptomycin to Amikacin-Vancomycin: Antibiotic Decontamination of Cardiovascular Homografts in Singapore
por: Heng, Wee Ling, et al.
Publicado: (2012)

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
por: Hoy, Sheridan M.
Publicado: (2021)

Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease
por: Marras, Theodore K., et al.
Publicado: (2022)

Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung disease
por: Jo, Kyung-Wook, et al.
Publicado: (2020)

Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use
por: Hoy, Sheridan M.
Publicado: (2021)

805. Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
por: Brown-Elliott, Barbara A, et al.
Publicado: (2018)

Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare
por: Yoo, Sang Hoon, et al.
Publicado: (2016)

Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2019)

Pulmonary Mycobacterium kyorinense infection secondary to cavitary pulmonary tuberculosis
por: Nagao, Genta, et al.
Publicado: (2022)

Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept)
por: Tanaka, Hiromu, et al.
Publicado: (2022)

Thin-Section CT Findings of Nontuberculous Mycobacterial Pulmonary Diseases: Comparison Between Mycobacterium avium-intracellulare Complex and Mycobacterium abscessus Infection
por: Chung, Myung Jin, et al.
Publicado: (2005)

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
por: Winthrop, Kevin L., et al.
Publicado: (2021)

Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings
por: Morita, Atsuho, et al.
Publicado: (2022)

Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
por: Hashimoto, Kazuki, et al.
Publicado: (2023)

Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
por: Im, Soo Ah, et al.
Publicado: (2010)

Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease
por: Chang, Chia-Ling, et al.
Publicado: (2023)

A marmoset model for Mycobacterium avium complex pulmonary disease
por: Peters, Jay, et al.
Publicado: (2023)

Pulmonary Mycobacterium avium Complex Infection Showing Extensive Consolidation
por: Yamazoe, Masami, et al.
Publicado: (2022)

A Case of Cavitary Mycobacterium chimaera
por: Robinson, Bracha, et al.
Publicado: (2022)

1899. Core Outcome Domains for Mycobacterium avium complex Pulmonary Disease Clinical Trials: Mycobacterium avium complex Core Outcomes Research (MACCOR)
por: Varley, Cara D, et al.
Publicado: (2023)

Pulmonary cavitary Mycobacterium kyorinense (M. kyorinense) infection in an Australian woman
por: Muruganandan, Sanjeevan, et al.
Publicado: (2015)

Pulmonary Cavitary Disease Secondary to Mycobacterium xenopi Complicated by Respiratory Failure
por: Habib, Saad, et al.
Publicado: (2018)

A Rare Case of Pulmonary Cavitary Disease Caused by Mycobacterium xenopi
por: Dogra, Megha, et al.
Publicado: (2023)

Disseminated Mycobacterium avium complex infection in an immunocompetent pregnant woman
por: Song, Joon Young, et al.
Publicado: (2006)

Mutations in Streptomycin Resistance Genes and Their Relationship to Streptomycin Resistance and Lineage of Mycobacterium tuberculosis Thai Isolates
por: Hlaing, Yin Moe, et al.
Publicado: (2017)

Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex
por: Nagano, Hiroaki, et al.
Publicado: (2022)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
por: Wakabayashi, Hiroki, et al.
Publicado: (2019)

Exacerbating factors in elderly patients with Mycobacterium avium complex pulmonary disease
por: Kodaka, Norio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b51v85vr21q5i8j5ojm96ndm4n